In conclusion, our findings support a model in which early cytoskeletal dysfunction in PSP-RS arises from the convergence of Tau dysregulation, impaired structural homeostasis, and altered signaling pathways. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.